ArticleAnnals of diagnostic pathology2020

Clinicopathologic features of breast cancer reclassified as HER2-amplified by fluorescence in situ hybridization with alternative chromosome 17 probes.

Kristen C Blanton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.